Key result
LOT-CRT significantly narrowed QRS duration from 158.0 ms at baseline to 117.0 ms (P<0.01) and improved left ventricular ejection fraction from 32.8% to 45.0% at 3 months.
Why the study?
High nonresponder rates to biventricular pacing remain a challenge in cardiac resynchronization therapy, prompting evaluation of sequential left bundle branch area pacing followed by left ventricular pacing (LOT-CRT).
Does LOT-CRT improve QRS duration and LV function in patients with systolic HF and LBBB?
Observational (n=5)
Does LOT-CRT improve QRS duration and LV function in patients with systolic HF and LBBB?
Absolute Event Rate: 117% vs 158%
p-value: p=<0.01
LOT-CRT is feasible and associated with significant narrowing of QRS duration and improvement in LV function in a small series of patients with systolic HF and LBBB.
Supports hypothesis generation for LOT-CRT; should not yet change practice pending randomized trials.
Introduction: Cardiac resynchronization therapy via biventricular pacing is an established therapy for patients with heart failure. However, high nonresponder rates and inability to predict response remains a challenge. Recently left bundle branch area pacing (LBBAP) has been shown to be feasible and may also improve clinical outcomes. In this article we describe sequential LBBAP followed by left ventricular (LV) pacing (LOT-CRT) and assess the feasibility of LOT-CRT. Methods: The RV implantation site was positioned and the LBBAP lead was implanted using our methods. The QRS duration (QRSd) at baseline, during LBBAP, biventricular pacing, and LOT-CRT was measured. Results: LOT-CRT was successful in 5 patients (age 71.8 ± 5.1 years, men 3, ischemic 3). The QRSd at baseline was 158.0 ± 13.0 ms and significantly narrowed to 117.0 ± 6.7 ms during LOT-CRT (P < 0.01). During 3-month follow-up, LV ejection fraction improved from 32.8 ± 5.2 % to 45.0 ± 5.1% (P < 0.01), and New York Heart Association functional class changed from 3.25 ± 0.5 to 2.5 ± 0.6 (P < 0.05). A decrease in left ventricular end-diastolic dimension was observed, with widening from (68.2 ± 12.3) mm at baseline to (62.2 ± 11.3) mm at pacing (P < 0.05). The length of operation time was (152.0 ± 31.1) min. Conclusions: The study demonstrates that LOT-CRT is clinically feasible in patients with systolic HF and LBBB. LOT-CRT was associated with significant narrowing of QRSd and improvement in LV function, especially in patients with ischemic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2020) conducted an observational in Systolic heart failure and LBBB (n=5). LOT-CRT (sequential LBBAP followed by LV pacing) vs. Baseline was evaluated on QRS duration (p=<0.01). LOT-CRT significantly narrowed QRS duration from 158.0 ms at baseline to 117.0 ms (P<0.01) and improved left ventricular ejection fraction from 32.8% to 45.0% at 3 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: